The Porta Hepatis as a Site of Recurrence of Mucinous Appendiceal Neoplasms Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Restricted accessResearch articleFirst published online September, 2008
The Porta Hepatis as a Site of Recurrence of Mucinous Appendiceal Neoplasms Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
A successful new treatment for a particular disease may change the natural history of that disease as patients go on to longer survival. The goal of this study was to investigate the porta hepatis as a site of recurrence of appendiceal mucinous neoplasms.
Methods
A prospective database on patients with peritoneal dissemination of mucinous appendiceal neoplasms has been maintained for 21 years. In patients with complete cytoreduction, disease progression/recurrence in and around the porta hepatis has been noted as a new manifestation of this disease.
Results
In 710 patients treated for mucinous appendiceal cancer with a complete cytoreduction, 140 developed recurrent disease. Seven patients (5%) had disease recurrence in and around the porta hepatis. Four of the seven had biliary obstruction and three had masses within the liver hilum not causing bile duct obstruction. Four of the seven patients were successfully palliated by surgical procedures within the liver and biliary tree. Two patients were successfully palliated using a biliary stent and one patient was not treated.
Conclusions
Progression of mucinous neoplasms within the porta hepatis may be related to imperfect cytoreduction technique. Reoperative surgical treatment and biliary stents were beneficial in some of these patients.
SugarbakerP.H., JablonskiK.A.: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg, 221: 124–132, 1995.
2.
van RuthS., AchermanY.I.Z., van de VijverM.J., HartA.A., VerwaalV.J., ZoetmulderF.A.: Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol, 29: 682–688, 2003.
3.
DeracoM., BarattiD., IngleseM.G., AllariaB., AndreolaS., GavazziC., KusamuraS.: Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol, 11: 393–398, 2004.
4.
GunerZ., SchmidtU., DahlkeM.H., SchlittH.J., KlempnauerJ., PisoP.: Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis, 20: 155–160, 2005.
5.
LoungnarathR., CauseretS., BossardN., FaheezM., Sayag-BeaujardA.C., BrigandC., GillyF., GlehenO.: Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum, 48: 1372–1379, 2005.
6.
MurphyE.M., SextonR., MoranB.J.: Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum, 50: 37–42, 2007.
7.
StewartJHIV, ShenP., RussellG.B., BradleyR.F., HundleyJ.C., LoggieB.L., GeisingerK.R., LevineE.A.: Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol, 13: 624–634, 2006.
8.
SugarbakerP.H.: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?Lancet Oncol,7: 69–76, 2006.
9.
GlehenO., MohamedF., SugarbakerP.H.: Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg, 240: 278–285, 2004.
10.
YanT.D., BijelicL., SugarbakerP.H.: Critical analysis of treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol, 14: 2289–2299, 2007.
11.
CunliffeW.J., SugarbakerP.H.: Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg, 76: 1082–1090, 1989.
12.
Ortega-PerezG., SugarbakerP.H.: Right psoas muscle/aortoiliac groove recurrence: an unusual anatomic site for progression of epithelial tumors of the appendix. Int Surg, 87: 212–216, 2002.
13.
LiberaleG., EliasD., SiderisL., LasserP., MalkaD., SabourinJ.C., PocardM.: Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy. J Surg Oncol, 91: 73–76, 2005.
14.
CabanasJ., Gomes da SilvaR., GoldsteinP., VergheseM., SugarbakerP.H.: Recurrence of pseudomyxoma peritonei within the inguinal canal. Tumori, 91: 481–486, 2005.
15.
SebbagG., SugarbakerP.H., WalfischS., LevyI.: Chronic perineal fistula as a late failure manifestation of pseudomyxoma peritonei syndrome. Scand J Gastroenterol, 39: 1172–1174, 2004.
16.
CabanasJ., Gomes da SilvaR., ZappaL., EsquivelJ., CerrutoC., GoldsteinP., SugarbakerP.H.: Splenic metastases from mucinous neoplasms of the appendix and colon. Tumori, 92: 104–112, 2006.
17.
SmeenkR.M., VerwaalV.J., AntoniniN., ZoetmulderF.A.: Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg, 245: 104–109, 2007.
18.
RonnettB.M., KurmanR.J., ShmooklerB.M., SugarbakerP.H., YoungR.H.: The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol, 21: 1144–1155, 1997.
19.
SugarbakerP.: Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg, 89: 208–212, 2002.
20.
SugarbakerP.H.: Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res, 82: 79–100, 1996.
21.
CarmignaniC.P., SugarbakerT.A., BromleyC.M., SugarbakerP.H.: Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev, 22: 465–472, 2003.
22.
Vazquez VdeL., SugarbakerP.H.: Cholecystectomy, lesser omentectomy, and stripping of the omental bursa: a peritonectomy procedure. J Surg Oncol, 84: 45–49, 2003.
SugarbakerP.H.: Laser-mode electrosurgery. Cancer Treat Res, 82: 375–385, 1996.
25.
SugarbakerP.H., ChangD.: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol, 6: 727–731, 1999.
26.
LookM., ChangD., SugarbakerP.H.: Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer, 14: 35–41, 2004.
27.
BijelicL., YanT.D., SugarbakerP.H.: Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol, 14: 2281–2288, 2007.
28.
SugarbakerP.H.: Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol, 95: 93–96, 2007.
